久久精品一区二区日韩AⅤ_超碰在线97中文字幕 _国产日韩欧美视频二区_亚洲伦理久久精品资讯_欧美国产XXXX视频在线观看_综合无码一区二区三区四区五区_亚洲-级毛片www_精品国产成人嫩妇_日韩中文字幕精品视频在线_韩国日屁免费看1区2区欧美黄片_亚洲欧美激情专区_东京热加勒比国内精品_欧美精品一级一区二区_自愉自愉自产国产91_亚洲中文字幕av无码区

Jiangxi Keyuan Biopharm Co., Ltd. is located in Jishan Chemical Industrial Zone in Pengze County, Jiangxi Province. This Industrial Zone, as a provincial chemical zone authorized by Jiangxi Provincial People's Government, is situated at the foot of a hill and beside a river, showing distinctive geographic advantages. The company covers an area of 98000 square meters, including a building area of 32000 square meters. In addition to being equipped with consummated production and supporting facilities, the company has also been built with a new product R&D center. This has provided powerful technological support and driven forces to health development of the company.

With the philosophy of "creativity, Excellency and development", the company is committed to seek for in-depth development based on new product technology and excellent quality. In the future the company will reinforce its service sense to both new and old customers, offering thoughtful services while providing high-quality products. Our advancement and development cannot be separated with the great support of all customers.

Under the direction of the strategy of technological innovation and with the goal of developing biochemical engineering, our company has successfully developed multiple biotechnologies concerning chiral compound synthesis using biological enzyme as catalyzer. Products such as chiral mandelic acid series, chiral cyanohydrins series, intermediate and diphenylacetonitrile like atorvastatin are our hot-sale products with advantaged competitiveness all over the world. In the future, the company will further enhance its service, offer better products at competitive prices and quality service. At the same time, we highly appreciate the supports and help from all our customers. Let's cooperate together hand in hand and create a win-win situation as well as a bright future.